Vitamin D Supplementation for Premature Birth

Recruiting in Palo Alto (17 mi)

Age: < 18

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Phase 1 & 2

Waitlist Available

Sponsor: University of Alabama at Birmingham

Trial Summary

What is the purpose of this trial?

This trial is testing if giving very premature babies a high dose of vitamin D helps them more than a low dose. It focuses on extremely preterm infants who are fed human milk, aiming to support their bone growth and immune system.

Eligibility Criteria

This trial is for extremely preterm infants born at a gestational age of 28 weeks or less. Infants with terminal illnesses where life support is limited, or those with major congenital anomalies cannot participate.

Inclusion Criteria

Gestational age of 28 weeks or less

Exclusion Criteria

Terminal illness in whom decisions to withhold or limit life support have been made

My infant has a major birth defect.

Participant Groups

The study tests the effects of early vitamin D supplementation in very premature babies. They are randomly assigned to receive either high doses (intervention group) or low doses (control group) during their first two weeks after birth.

Group I: Vitamin D group Experimental Treatment 1 Intervention

Group II: Control group Placebo Group 1 Intervention

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

University of Alabama at Birmingham Birmingham, AL

Who Is Running the Clinical Trial?

University of Alabama at Birmingham Lead Sponsor

References